ERD

c4c | conect4children (COllaborative Network for European Clinical Trials For Children)

01-05-2018

-

30-04-2025

Show more information

Organisation ELI LILLY AND COMPANY LTD

ConcePTION | Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation

01-04-2019

-

31-12-2024

Show more information

Organisation ELI LILLY AND COMPANY LTD

IDEA-FAST | Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases

01-11-2019

-

30-04-2026

Show more information

Organisation ELI LILLY AND COMPANY LTD

LITMUS | Liver Investigation: Testing Marker Utility in Steatohepatitis

01-11-2017

-

29-02-2024

Show more information

Organisation ELI LILLY AND COMPANY LTD

INNODIA | Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797

01-11-2015

-

31-10-2023

Show more information

Organisation ELI LILLY AND COMPANY LTD

IMI-PainCare | Improving the care of patients suffering from acute or chronic pain

01-04-2018

-

31-03-2023

Show more information

Organisation ELI LILLY AND COMPANY LTD

INNODIA HARVEST | Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA

01-05-2020

-

30-04-2024

Show more information

Organisation ELI LILLY AND COMPANY LTD

Gravitate-Health | Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment

01-11-2020

-

31-10-2025

Show more information

Organisation ELI LILLY AND COMPANY LTD

CARDIATEAM | CARdiomyopathy in type 2 DIAbetes mellitus

01-03-2019

-

28-02-2026

Show more information

Organisation ELI LILLY AND COMPANY LTD

SOPHIA | Stratification of Obesity Phenotypes to Optimize Future Therapy

01-06-2020

-

31-05-2025

Show more information

Organisation ELI LILLY AND COMPANY LTD

ImmUniverse | Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies

01-01-2020

-

31-12-2024

Show more information

Organisation ELI LILLY AND COMPANY LTD

PARADIGM | Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.

01-03-2018

-

30-11-2020

Show more information

Organisation ELI LILLY AND COMPANY LTD

DO-IT | Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055

01-02-2017

-

31-01-2019

Show more information

Organisation ELI LILLY AND COMPANY LTD

BEAt-DKD | Biomarker Enterprise to Attack DKD - Sofia ref.: 115974

01-09-2016

-

31-08-2023

Show more information

Organisation ELI LILLY AND COMPANY LTD

ITCC-P4 | ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064

01-01-2017

-

31-12-2023

Show more information

Organisation ELI LILLY AND COMPANY LTD

iCARE4CVD | INDIVIDUALISED CARE FROM EARLY RISK OF CARDIOVASCULAR DISEASE TO ESTABLISHED HEART FAILURE

01-10-2023

-

31-03-2028

Show more information

Organisation ELI LILLY AND COMPANY

PREFER | Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966

01-10-2016

-

31-05-2022

Show more information

Organisation ELI LILLY AND COMPANY LTD

IMMUcan | Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts

01-03-2019

-

31-08-2025

Show more information

Organisation ELI LILLY AND COMPANY LTD

ADAPT-SMART | Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890

01-07-2015

-

30-04-2018

Show more information

Organisation ELI LILLY AND COMPANY LTD

RHAPSODY | Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification - Sofia ref.: 115881

01-04-2016

-

30-09-2021

Show more information

Organisation ELI LILLY AND COMPANY LTD

TransBioLine | Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease

01-02-2019

-

31-01-2025

Show more information

Organisation ELI LILLY AND COMPANY LTD

Hypo-RESOLVE | Hypoglycaemia - REdefining SOLutions for better liVEs

01-05-2018

-

31-10-2023

Show more information

Organisation ELI LILLY AND COMPANY LTD

PREMIER | Prioritisation and Risk Evaluation of Medicines in the EnviRonment

01-09-2020

-

31-08-2026

Show more information

Organisation ELI LILLY AND COMPANY LTD

ROADMAP | Real world Outcomes across the AD spectrum for better care: Multimodal data Access Platform - Sofia ref.: 116020

01-11-2016

-

31-10-2018

Show more information

Organisation ELI LILLY AND COMPANY LTD

FAIRplus | FAIRplus

01-01-2019

-

31-12-2022

Show more information

Organisation ELI LILLY AND COMPANY LTD

H2O | H2O Health Outcomes Observatory

01-10-2020

-

30-09-2025

Show more information

Organisation ELI LILLY AND COMPANY LTD

EHDEN | European Health Data and Evidence Network

01-11-2018

-

31-10-2024

Show more information

Organisation ELI LILLY AND COMPANY LTD

TransQST | Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030

01-01-2017

-

31-08-2022

Show more information

Organisation ELI LILLY AND COMPANY LTD

PRISM | Psychiatric Ratings using Intermediate Stratified Markers - Sofia ref.: 115916

01-04-2016

-

30-09-2019

Show more information

Organisation ELI LILLY AND COMPANY LTD

IMPRiND | Inhibiting Misfolded protein PRopagation in Neurodegenerative Diseases - Sofia ref.: 116060

01-03-2017

-

28-02-2022

Show more information

Organisation ELI LILLY AND COMPANY LTD

Projects overview

Selected filters:

c4c | conect4children (COllaborative Network for European Clinical Trials For Children)

ConcePTION | Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation

IDEA-FAST | Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases

LITMUS | Liver Investigation: Testing Marker Utility in Steatohepatitis

INNODIA | Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797

IMI-PainCare | Improving the care of patients suffering from acute or chronic pain

INNODIA HARVEST | Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA

Gravitate-Health | Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment

CARDIATEAM | CARdiomyopathy in type 2 DIAbetes mellitus

SOPHIA | Stratification of Obesity Phenotypes to Optimize Future Therapy

ImmUniverse | Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies

PARADIGM | Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.

DO-IT | Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055

BEAt-DKD | Biomarker Enterprise to Attack DKD - Sofia ref.: 115974

ITCC-P4 | ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064

iCARE4CVD | INDIVIDUALISED CARE FROM EARLY RISK OF CARDIOVASCULAR DISEASE TO ESTABLISHED HEART FAILURE

PREFER | Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966

IMMUcan | Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts

ADAPT-SMART | Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890

RHAPSODY | Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification - Sofia ref.: 115881

TransBioLine | Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease

Hypo-RESOLVE | Hypoglycaemia - REdefining SOLutions for better liVEs

PREMIER | Prioritisation and Risk Evaluation of Medicines in the EnviRonment

ROADMAP | Real world Outcomes across the AD spectrum for better care: Multimodal data Access Platform - Sofia ref.: 116020

FAIRplus | FAIRplus

H2O | H2O Health Outcomes Observatory

EHDEN | European Health Data and Evidence Network

TransQST | Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030

PRISM | Psychiatric Ratings using Intermediate Stratified Markers - Sofia ref.: 115916

IMPRiND | Inhibiting Misfolded protein PRopagation in Neurodegenerative Diseases - Sofia ref.: 116060